Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 24;12(8):e060361.
doi: 10.1136/bmjopen-2021-060361.

Impact of Helicobacter pylori eradication timing on the risk of thromboembolism events in patients with peptic ulcer disease: a population-based cohort study

Jung-Nien Lai #  1 , Yi-Jun Liao #  2   3 , Cheng-Li Lin  4 , Chi-Sen Chang  5 , Yen-Chun Peng  6   5   7
Affiliations

Impact of Helicobacter pylori eradication timing on the risk of thromboembolism events in patients with peptic ulcer disease: a population-based cohort study

Jung-Nien Lai et al. BMJ Open. .

Abstract

Objectives: To evaluate the impact of Helicobacter pylori eradication on venous thromboembolism (VTE) events, and the differences between early and late treatment timing.

Design: A population-based cohort study.

Setting: Taiwan's National Health Insurance Research Database.

Participants: A total of 6736 patients who received H. pylori eradication therapy from 2000 to 2010 were identified. We randomly selected 26 944 subjects matching in gender, age and baseline year as comparison cohort.

Primary and secondary outcome measures: The incidence rate ratios of VTE in the H. pylori eradication cohorts to that of the control cohort were examined. Multivariable Cox proportional hazard regression analysis was used to estimate the relative HRs and 95% CI of VTE development.

Results: The total incidence rate of VTE was observed in the late H. pylori eradication cohort, the early H. pylori eradication cohort and the control cohort (15.2, 3.04 and 2.91 per 1000 person-years, respectively). An age-specific trend was found in the late H. pylori eradication cohort, with a greater rate of VTE in the 50-65 years and more than 65 years age groups (adjusted HR 5.44; 95% CI 4.21 to 7.03 and 3.13; 95% CI 2.46 to 3.99). With comorbidities, the late H. pylori eradication cohort seemed to have the highest VTE incidence rate and adjusted HR (4.48, 95% CI 3.78 to 5.30).

Conclusions: Late H. pylori eradication was associated with a significantly increased risk of VTE, and there was a significantly greater risk of VTE in patients with female gender, age more than 50 years and with comorbidities.

Keywords: Adult gastroenterology; Gastrointestinal infections; Thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. O'Connor A, O'Morain CA, Ford AC. Population screening and treatment of Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 2017;14:230–40. 10.1038/nrgastro.2016.195 - DOI - PubMed
    1. Suzuki H, Franceschi F, Nishizawa T, et al. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2011;16 Suppl 1:65–9. 10.1111/j.1523-5378.2011.00883.x - DOI - PubMed
    1. Franceschi F, Zuccalà G, Roccarina D, et al. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol 2014;11:234–42. 10.1038/nrgastro.2013.243 - DOI - PubMed
    1. Chey WD, Leontiadis GI, Howden CW, et al. Acg clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol 2017;112:212–39. 10.1038/ajg.2016.563 - DOI - PubMed
    1. Kawai T, Moriyasu F, Tsuchida A. Key issues associated with Helicobacter pylori eradication. Digestion 2016;93:19–23. 10.1159/000441667 - DOI - PubMed

Substances